| Literature DB >> 34985568 |
Marta Klimek-Szczykutowicz1,2, Michał Dziurka3, Ivica Blažević4, Azra Đulović4, Anna Apola5, Halina Ekiert1, Agnieszka Szopa6.
Abstract
The study has proved the stimulating effects of different strategies of treatments with elicitors on the production of glucosinolates (GSLs), flavonoids, polyphenols, saccharides, and photosynthetic pigments in watercress (Nasturtium officinale) microshoot cultures. The study also assessed antioxidant and anti-melanin activities. The following elicitors were tested: ethephon (ETH), methyl jasmonate (MeJA), sodium salicylate (NaSA), and yeast extract (YeE) and were added on day 10 of the growth period. Cultures not treated with the elicitor were used as control. The total GSL content estimations and UHPLC-DAD-MS/MS analyses showed that elicitation influenced the qualitative and quantitative profiles of GSLs. MeJA stimulated the production of gluconasturtiin (68.34 mg/100 g dried weight (DW)) and glucobrassicin (65.95 mg/100 g DW). The elicitation also increased flavonoid accumulation (max. 1131.33 mg/100 g DW, for 100 μM NaSA, collection after 24 h). The elicitors did not boost the total polyphenol content. NaSA at 100 μM increased the production of total chlorophyll a and b (5.7 times after 24 h of treatment), and 50 μM NaSA caused a 6.5 times higher production of carotenoids after 8 days of treatment. The antioxidant potential (assessed with the CUPRAC FRAP and DPPH assays) increased most after 24 h of treatment with 100 μM MeJA. The assessment of anti-melanin activities showed that the microshoot extracts were able to cause inhibition of tyrosinase (max. 27.84% for 1250 µg/mL). KEY POINTS: • Elicitation stimulated of the metabolite production in N. officinale microshoots. • High production of pro-health glucosinolates and polyphenols was obtained. • N. officinale microshoots have got tyrosinase inhibition potential. • The antioxidant potential of N. officinale microshoots was evaluated.Entities:
Keywords: Antioxidant potential; Elicitation; Glucosinolates; In vitro cultures; Nasturtium officinale; Polyphenols; Tyrosinase inhibition
Mesh:
Substances:
Year: 2022 PMID: 34985568 PMCID: PMC8763773 DOI: 10.1007/s00253-021-11743-8
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Fig. 1Examples of the morphological appearance of N. officinale control and experimental in vitro cultures after 8 days of elicitation. Used concentrations of elicitors: A control, B 25 µM ETH, C 50 µM ETH, D 50 µM MeJA, E 100 µM MeJA, F 50 µM NaSA, G 100 µM NaSA, H 1 mg/mL YeE, I 3 mg/mL YeE. Figure 1 is corresponding with Supplementary Fig. S2
Maximum values of the growth index (Gi ± SD) for N. officinale control and experimental in vitro cultures after elicitation (p < 0.05 vs control, n = 6)
| Elicitor | Gi ± SD maximal value | Elicitor concentration | Harvest time after elicitor treatments | Gi ± SD of C |
|---|---|---|---|---|
| ETH | 30.26 ± 0.03 | 25 μM | 4 days | 29.91 ± 0.15 |
| MeJA | 31.59 ± 0.01 | 100 μM | 6 days | 30.17 ± 0.32 |
| NaSA | 31.04 ± 0.07 | 50 μM | 48 h | 30.32 ± 0.07 |
| YeE | 29.27 ± 0.07 | 3 mg/mL | 48 h | 30.32 ± 0.07 |
*Table 1 is corresponding to Supplementary Table S1
Maximum total glucosinolates (mg/100 g DW ± SD), total flavonoids (mg of RE/100 g DW ± SD), total polyphenols (mg of GAL/100 g DW ± SD), and total soluble saccharides (g of GLU/100 g DW ± SD) for N. officinale control and experimental in vitro cultures after elicitation (p < 0.05 vs control, n = 6)
| Glucosinolates a | Flavonoids b | Polyphenols b | Soluble saccharides b | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Maximal total content (mg/100 g DW ± SD) | Elicitor concentration | Harvest time after elicitor treatment | Maximal total content (mg/100 g DW ± SD) | Elicitor concentration | Harvest time after elicitor treatment | Maximal total content (mg/100 g DW ± SD) | Elicitor concentration | Harvest time after elicitor treatment | Maximal total content (g/100 g DW ± SD) | Elicitor concentration | Harvest time after elicitor treatment | |
| C | 234.35 ± 14.71 | nt* | 4 days | 984.83 ± 26.72 | nt | 4 days | 336.89 ± 8.03 | nt | 6 days | 7.62 ± 0.46 | nt | 8 days |
| ETH | 150.71 ± 11.83 | 25 μM | 4 days | 1060.80 ± 60.75 | 50 μM | 48 h | 314.27 ± 19.20 | 25 μM | 24 h | 6.96 ± 0.35 | 50 μM | 24 h |
| MeJA | 211.19 ± 14.04 | 50 μM | 24 h | 1037.47 ± 26.80 | 100 μM | 24 h | 276.29 ± 19.66 | 100 μM | 24 h | 8.30 ± 0.48 | 100 μM | 48 h |
| NaSA | 66.18 ± 7.20 | 50 μM | 4 days | 1131.33 ± 9.85 | 100 μM | 24 h | 293.21 ± 13.55 | 50 μM | 8 days | 9.23 ± 0.34 | 50 μM | 48 h |
| YeE | 11.45 ± 0.91 | 3 mg/mL | 6 days | 824.18 ± 25.57 | 1 mg/mL | 8 days | 265.89 ± 7.61 | 1 mg/mL | 4 days | 6.53 ± 0.28 | 3 mg/mL | 24 h |
*nt, no treatment; aCalculated from the content of individual GSLs given in Table 3; bResults are corresponding to Supplementary Table S2
Qualitative and quantitative (mg/100 g DW ± SD) profiles of GSL compounds detected in N. officinale control and selected experimental in vitro cultures after elicitation, as confirmed by UHPLC-DAD-MS/MS
| Subgroups | No.* | Glucosinolate (GSL) (trivial name) | [M + Na]+ | Contents (mg/100 g DW ± SD) | |||||
|---|---|---|---|---|---|---|---|---|---|
| C 4 days | 25 μM ETH 4 days | 50 μM MeJA 24 h | 50 μM NaSA 4 days | 3 mg/mL YeE 6 days | |||||
| Methionine derived | 1 | 6-(Methylsulfinyl)hexyl GSL (glucohesperin) | 5.50 | 408 | nd | tr | nd | nd | nd |
| 2 | 7-(Methylsulfinyl)heptyl GSL | 6.55 | 422 | tr | tr | tr | tr | tr | |
| 3 | 8-(Methylsulfinyl)octyl GSL (glucohirsutin) | 7.58 | 436 | tr | tr | tr | tr | nd | |
| 4 | 7-(Methylsulfanyl)heptyl GSL | 10.97 | 406 | tr | nd | tr | tr | nd | |
| 5 | 8-(Methylsulfanyl)octyl GSL | 12.70 | 420 | tr | nd | nd | tr | nd | |
| Phenylalanine derived | 6 | 2-Phenylethyl GSL (gluconasturtiin) | 8.20 | 366 | 23.16 ± 4.16 | 42.79 ± 4.83 | 68.34 ± 5.14 | 7.17 ± 0.19 | tr |
| Tryptophan derived | 7 | 4-Hydroxyindol-3-ylmethyl GSL (4-hydroxyglucobrassicin) | 5.85 | 407 | 12.00 ± 1.89 | 1.36 ± 0.10 | 5.26 ± 1.57 | 0.55 ± 0.00 | nd |
| 8 | Indol-3-ylmethyl GSL (glucobrassicin) | 7.64 | 391 | 46.28 ± 3.20 | 34.36 ± 0.67 | 65.95 ± 0.49 | 4.15 ± 0.12 | tr | |
| 9 | 4-Methoxyindol-3-ylmethyl GSL (4-methoxyglucobrassicin) | 8.35 | 421 | 152.91 ± 5.46 | 72.20 ± 6.23 | 71.64 ± 6.84 | 54.31 ± 6.89 | 11.45 ± 0.91 | |
[M + Na]+, sodium adduct of desulfoglucosinolate; tr, trace amounts < 0.1 mg/100 g DW; nd, not detected
*Numbers are corresponding to Supplementary Fig. S1
Maximum amounts of the main phenolic compounds (mg/100 g DW ± SD) in extracts from N. officinale control and experimental in vitro cultures after elicitation (p < 0.05 vs control, n = 6)
| Polyphenol compounds | Maximal content (mg/100 g DW ± SD) | Elicitor | Elicitor concentration | Harvest time after elicitor treatment | C (mg/100 g DW ± SD) |
|---|---|---|---|---|---|
| 38.76 ± 0.72 | MeJA | 100 μM | 6 days | 64.38 ± 9.26 | |
| Ferulic acid | 17.76 ± 2.07 | NaSA | 50 μM | 8 days | 16.46 ± 0.09 |
| Rutoside | 17.00 ± 1.45 | NaSA | 100 μM | 8 days | 21.17 ± 2.67 |
*Table 4 is corresponding to Supplementary Table S3
Maximum amounts of photosynthetic pigments (mg/100 g DW ± SD) in extracts from N. officinale control and experimental in vitro cultures after elicitation (p < 0.05 vs control, n = 6)
| Photosynthetic pigments | Maximal content (mg/100 g DW ± SD) | Elicitor | Elicitor concentration | Harvest time after elicitor treatment | C (mg/100 g DW ± SD) |
|---|---|---|---|---|---|
| Chlorophyll | 89.01 ± 2.53 | NaSA | 100 μM | 24 h | 12.33 ± 0.33 |
| Chlorophyll | 58.25 ± 1.87 | NaSA | 100 μM | 24 h | 13.31 ± 0.41 |
| Chlorophyll | 147.32 ± 4.48 | NaSA | 100 μM | 24 h | 25.64 ± 0.73 |
| Carotenoids | 10.83 ± 1.14 | NaSA | 50 μM | 8 days | 1.67 ± 0.06 |
*Table 5 is corresponding to Supplementary Table S4
Maximum antioxidant activity, estimated by the CUPRAC, DPPH, and FRAP methods (expressed in mmol TE/100 g DW ± SD), of extracts from N. officinale control and experimental in vitro cultures after elicitation (p < 0.05 vs control, n = 6)
| Polyphenol compounds | Maximal antioxidant activity | Elicitor | Elicitor concentration | Harvest time after elicitor treatment | C |
|---|---|---|---|---|---|
| CUPRAC | 2.97 ± 0.03 | MeJA | 100 μM | 24 h | 1.63 ± 0.06 |
| DPPH | 2.30 ± 2.09 | ETH | 50 μM | 6 days | 1.04 ± 0.01 |
| FRAP | 0.83 ± 0.02 | MeJA | 100 μM | 24 h | 0.40 ± 0.01 |
*Table 6 is corresponding to Supplementary Table S5
Inhibition of tyrosinase activity (% ± SD) by the extracts obtained from elicitor-treated N. officinale microshoot cultures (p < 0.05 vs control, n = 6)
| Positive control | |||
|---|---|---|---|
| Inhibition of tyrosinase activity | Kojic acid (µg) | Inhibition of tyrosinase activity | |
| 1250 | 27.84 ± 0.40 | 5.5 | 30.62 ± 0.36 |
| 1000 | 22.03 ± 0.30 | 4.5 | 24.93 ± 0.07 |
| 750 | 16.69 ± 0.22 | 3.5 | 20.69 ± 0.15 |
| 500 | 11.05 ± 0.16 | 2.5 | 13.65 ± 0.06 |
| 250 | 5.41 ± 0.06 | 1.5 | 8.54 ± 0.04 |